Die EMA warnt vor "heftigen Monatsblutungen" bei Comirnaty und Spikevax.
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 24 - 27 October 2022 …
EMA recommends measures to minimise risk of serious side effects with Janus kinase inhibitors for …
- Report
Social networks
Change post
Remove post